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influenza and play some part in prevention. The
EMEA has produced guidance to aid national
decisions on procurement and use of antivirals.
The European Centre for Disease Prevention and
Control monitors the epidemiological situation and is
currently developing a preparedness assessment tool to
be field tested in the coming weeks. The centre and the
European Commission are also supporting the Euro-
pean influenza surveillance scheme, which is continu-
ously adapting its epidemiological and virological
monitoring to the threat of an H5N1 pandemic. On the
EU level, links between human and veterinarian medicine
exist but need to be further strengthened. More work is
especially needed for effective crisis communication.
A pandemic will occur in the future. European
institutions are taking this threat seriously, with efforts
that will eventually pay off through reduced morbidity
and mortality in the next pandemic. Meanwhile, activi-
ties to prepare for an influenza pandemic also make
Europe better equipped to tackle seasonal influenza
and other major public health crises. This is worth the
investment and efforts.
Denis Coulombier head of unit for preparedness and
response
(denis.coulombier@ecdc.eu.int)
Karl Ekdahl strategic adviser to the director
European Centre for Disease prevention and Control (ECDC), SE-171
86 Solna, Sweden
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Survival after stroke in south London
Is apparently higher in black patients than in white ones
Few studies have compared the incidence andoutcome of stroke in black and white peoplefrom the same population. Two population
based stroke registers in US cities1 2 and one in the
United Kingdom (the south London stroke register)3
found twice the incidence of stroke adjusted for age
and sex in black people than in white people. Adjusting
for socioeconomic status in the south London register
attenuated but did not abolish this excess.3 None of
these registers has found a significant difference
between black people and white people in survival
after stroke, and all have therefore attributed the excess
mortality in black people to a higher incidence of
stroke.2–4
The south London register now includes more
than 2000 patients with a first ever stroke over seven
years and has accrued 6000 person years of follow-up.5
Such studies are rare these days even in the UK, whose
universal healthcare system makes it an ideal location
for population based epidemiological research. The
challenges include obtaining ethical approval for
observational studies without explicit consent, getting
long term grants to support the research, and
maintaining the enthusiasm of the research team and
its collaborators.
In today’s BMJ, Wolfe et al present their updated
comparison of survival after stroke in black people and
white people. On the face of it, the findings are surpris-
ing: black patients seemed to have a survival advantage,
with a reduction of about a third in the relative risk of
dying, corresponding to an increased median survival
time of almost 14 months.5
So is this finding real or a methodological artefact,
and if artefact what are the possible reasons? One pos-
sible methodological explanation is differential under-
ascertainment of stroke cases between ethnic groups.
The researchers on the south London register have
previously assessed completeness of case ascertain-
ment by using capture-recapture methods, implying
that it is almost 90% complete for both black people
and white people.6 However, the validity of these meth-
ods for stroke registers has been questioned.7 8 Also the
proportions of cases in the register that were notified
by general practitioners (14%) and not admitted to
hospital (15%) were lower than in the UK based
Oxfordshire Community Stroke Project and its succes-
sor, the Oxford vascular study, in both of which most
cases were notified by general practitioners, and over
40% were not admitted to hospital.8–10 This may
indicate that the register missed a disproportionate
number of patients with mild strokes who were not
admitted to hospital. If this affected more white
patients than black ones (for example, if more black
patients sought care directly at hospital rather than at
their general practice, and white patients obtained pri-
vate health care outside the NHS more often, making
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them harder to detect) it could cause an apparent
excess stroke incidence and survival advantage in black
people.
Alternatively, can the findings be explained by
residual confounding? Black patients in the south
London register were younger (by about 10 years), had
a higher proportion of lacunar ischaemic strokes
(which have a very low case fatality), and were more
likely to be admitted to hospital and be cared for on a
stroke unit,5 all of which would tend to improve
survival. However, the survival advantage persisted
after adjustment for demographic variables, socioeco-
nomic status, prior risk factors and their management,
stroke severity, and acute stroke management. Adjust-
ment for stroke severity in particular may have been
incomplete as analyses were stratified by the main
pathological types of stroke (ischaemic stroke, intracer-
ebral haemorrhage, and subarachnoid haemorrhage),
but it is unclear whether adjustment for the
distributions of ischaemic stroke subtypes was under-
taken.
However, the combination of differential case
ascertainment and residual confounding could prob-
ably not explain all of the difference in survival, so what
could explain a genuine ethnic difference? Subgroup
analyses found that the difference was confined to
older patients and those with minimal disability before
their stroke,5 but as only 166 black patients died this
could be a chance finding. The authors propose that
better control of risk factors among black patients may
partly explain their better survival, and that the
migrant population from Africa and the Caribbean
may be particularly healthy.5 But this would not explain
the increased incidence of stroke in black people. Like
studies in the US,11 12 the south London register found
a higher prevalence of hypertension and diabetes and
a lower prevalence of ischaemic heart disease and
atrial fibrillation in black stroke patients than in white
ones. Such differences in risk factors may differentially
influence particular causes of death after stroke, such
as recurrent stroke or myocardial infarction. Finally,
black patients could have better community care provi-
sion than white patients. Although the south London
register’s researchers have found no clear difference in
the provision of NHS care after stroke between ethnic
groups,13 they have not yet studied the care provided by
families and other social networks, which may differ
between ethnic groups.
The results are intriguing, and should encourage
further studies of these possible explanations in south
London and elsewhere.
Cathie Sudlow clinical senior lecturer
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Cardiac impairment or heart failure?
“Heart failure” confuses doctors and patients and needs renaming
“There is no disease that you either have ordon’t have—except perhaps sudden deathor rabies. All other diseases you either have
a little or a lot of,” said Geoffrey Rose.1 This is true of
“heart failure”—everybody can have a bit if they try
hard enough, by physical exertion or even by
emotional shock.2 But, apart from transient induced
cardiac overload, the term can be used to mean
anything from asymptomatic systolic dysfunction to
imminent death from pulmonary oedema. Because of
widely varying definitions, the epidemiology of heart
failure can become almost uninterpretable, with
estimates of its prevalence in the United Kingdom
varying from 500 000 to 3 million.3 Moreover, qualita-
tive studies show that many patients are never told that
they have heart failure because doctors are under-
standably reluctant to use the term.4 When a label
confuses doctors and impairs communication with
patients, it seems sensible to change the label.
The recent increase in interest in heart failure
began with interventional studies among highly
selected patients. They were mainly men aged 60-65 on
average, with a history of myocardial infarction or car-
diomyopathy and a left systolic ejection fraction of less
than 30-35% as measured by cardiac catherisation or
radionuclide ventriculography. After initial success in
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